Cue Biopharma Inc. (CUE)
1.29
0.07 (5.74%)
At close: Jan 15, 2025, 11:38 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -2.38 | -1.92 | -8.01 | -8.01 | -9.53 | -2.43 | -10.33 | -31.35 | -124.46 |
| PS Ratio | 22.00 | 81.59 | 23.68 | 113.78 | 101.19 | 82.82 | n/a | n/a | n/a |
| PB Ratio | 3.26 | 1.55 | 5.40 | 4.55 | 6.41 | 2.79 | 3.90 | 15.82 | 34.60 |
| P/FCF Ratio | -3.02 | -2.42 | -8.9 | -10.85 | -11.34 | -3.35 | -17.92 | -37.02 | -99.53 |
| P/OCF Ratio | -3.02 | -2.43 | -9.11 | -11.04 | -11.36 | -3.58 | -19.69 | -40.22 | -144.82 |
| OCF/S Ratio | -7.28 | -33.57 | -2.6 | -10.3 | -8.91 | -23.11 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.40 | 0.29 | 0.15 | 0.09 | 0.11 | n/a | 0.04 | n/a | n/a |
| Quick Ratio | 3.01 | 6.68 | 5.35 | 5.36 | 3.94 | 6.53 | 12.13 | 14.18 | 19.01 |
| Current Ratio | 3.01 | 6.68 | 5.35 | 5.36 | 5.24 | 6.53 | 12.17 | 14.18 | 19.01 |
| Asset Turnover | 0.09 | 0.01 | 0.18 | 0.03 | 0.05 | 0.03 | n/a | n/a | n/a |
| Interest Coverage | -41.89 | -74.56 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -1.37 | -0.8 | -0.67 | -0.57 | -0.67 | -1.15 | -0.38 | -0.5 | -0.28 |
| Return on Assets (ROA) | -0.82 | -0.58 | -0.53 | -0.45 | -0.51 | -0.86 | -0.35 | -0.47 | -0.26 |
| Return on Capital (ROIC) | -1.17 | -0.67 | -0.62 | -0.54 | -0.61 | -0.99 | -0.38 | -0.5 | -0.28 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -593.93% | -45.04% | 111.90% | -963.48% | -694.9% | -2.40K% | n/a | n/a | n/a |
| Net Profit Margin | -924.1% | -4.24K% | -295.56% | -1.42K% | -1.06K% | -3.41K% | n/a | n/a | n/a |
| Pretax Profit Margin | -924.1% | -4.26K% | -292.25% | -1.41K% | -1.05K% | -3.34K% | n/a | n/a | n/a |
| Operating Profit Margin | -949.89% | -4.27K% | -292.56% | -1.43K% | -1.06K% | -3.39K% | n/a | n/a | n/a |
| FCF Margin | -727.89% | -3.37K% | -266.04% | -1.05K% | -891.94% | -2.47K% | n/a | n/a | n/a |
| EBITDA Margin | -838.83% | -4.05K% | -304.15% | -1.39K% | -1.04K% | -3.32K% | n/a | n/a | n/a |